Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway
Xiaoming Jin,* Riming He,* Yunxin Lin, Jiahui Liu, Yuzhi Wang, Zhongtang Li, Yijiao Liao, Shudong Yang Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, 51803...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-11-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/shenshuaifu-granule-attenuates-acute-kidney-injury-by-inhibiting-ferro-peer-reviewed-fulltext-article-DDDT |
| _version_ | 1797627874941861888 |
|---|---|
| author | Jin X He R Lin Y Liu J Wang Y Li Z Liao Y Yang S |
| author_facet | Jin X He R Lin Y Liu J Wang Y Li Z Liao Y Yang S |
| author_sort | Jin X |
| collection | DOAJ |
| description | Xiaoming Jin,* Riming He,* Yunxin Lin, Jiahui Liu, Yuzhi Wang, Zhongtang Li, Yijiao Liao, Shudong Yang Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, 518033, People’s Republic of China*These authors contributed equally to this workCorrespondence: Shudong Yang, Email shudong_yang@126.comBackground: Acute kidney injury (AKI) is a common clinical condition resulting in a rapid decline in renal function, and requires improvement in effective preventive measures. Ferroptosis, a novel form of cell death, is closely related to AKI. Shenshuaifu granule (SSF) has been demonstrated to prevent AKI through suppressing inflammation and apoptosis.Objective: This study aimed to explore whether SSF can inhibit ferroptosis in AKI.Methods: Active ingredients in SSF were detected through HPLC-MS/MS, and their binding abilities with ferroptosis were evaluated by molecular docking. Then, male C57/BL/6J mice were randomly divided into control, cisplatin, and cisplatin+SSF groups. In the latter two groups, mice were intraperitoneally injected with 20 mg/kg of cisplatin. For five consecutive days prior to cisplatin injection, mice in the cisplatin+SSF group were gavaged with 5.2 g/kg of SSF per day. 72 h after cisplatin injection, the mice were sacrificed. Serum creatinine (SCr) and blood urea nitrogen (BUN) were measured to evaluate renal function. H&E and PAS staining were used to observe pathological damage of kidney. Cell death was observed by TUNEL staining, and iron accumulation in kidneys of mice was detected by Prussian blue staining. Western blotting, immunohistochemistry, and immunofluorescence were used to investigate the presence of inflammation, oxidative stress, mitochondrial dysfunction, iron deposition, and lipid peroxidation in mouse kidneys.Results: Active ingredients in SSF had strong affinities with ferroptosis. SSF reduced SCr (p< 0.01) and BUN (p< 0.0001) levels, pathological damage (p< 0.0001), dead cells in the tubular epithelium (p< 0.0001) and iron deposition (p< 0.01) in mice with cisplatin induced AKI. And SSF downregulated macrophage infiltration (p< 0.01), the expressions of high mobility group box 1 (HMGB1, p< 0.05) and interleukin (IL)-17 (p< 0.05), upregulated superoxide dismutase (SOD) 1 and 2 (p< 0.01), and catalase (CAT, p |
| first_indexed | 2024-03-11T10:31:45Z |
| format | Article |
| id | doaj.art-77bd4e3e976f46999ddcd2b0de827321 |
| institution | Directory Open Access Journal |
| issn | 1177-8881 |
| language | English |
| last_indexed | 2024-03-11T10:31:45Z |
| publishDate | 2023-11-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Drug Design, Development and Therapy |
| spelling | doaj.art-77bd4e3e976f46999ddcd2b0de8273212023-11-14T17:11:38ZengDove Medical PressDrug Design, Development and Therapy1177-88812023-11-01Volume 173363338388152Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 PathwayJin XHe RLin YLiu JWang YLi ZLiao YYang SXiaoming Jin,* Riming He,* Yunxin Lin, Jiahui Liu, Yuzhi Wang, Zhongtang Li, Yijiao Liao, Shudong Yang Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, 518033, People’s Republic of China*These authors contributed equally to this workCorrespondence: Shudong Yang, Email shudong_yang@126.comBackground: Acute kidney injury (AKI) is a common clinical condition resulting in a rapid decline in renal function, and requires improvement in effective preventive measures. Ferroptosis, a novel form of cell death, is closely related to AKI. Shenshuaifu granule (SSF) has been demonstrated to prevent AKI through suppressing inflammation and apoptosis.Objective: This study aimed to explore whether SSF can inhibit ferroptosis in AKI.Methods: Active ingredients in SSF were detected through HPLC-MS/MS, and their binding abilities with ferroptosis were evaluated by molecular docking. Then, male C57/BL/6J mice were randomly divided into control, cisplatin, and cisplatin+SSF groups. In the latter two groups, mice were intraperitoneally injected with 20 mg/kg of cisplatin. For five consecutive days prior to cisplatin injection, mice in the cisplatin+SSF group were gavaged with 5.2 g/kg of SSF per day. 72 h after cisplatin injection, the mice were sacrificed. Serum creatinine (SCr) and blood urea nitrogen (BUN) were measured to evaluate renal function. H&E and PAS staining were used to observe pathological damage of kidney. Cell death was observed by TUNEL staining, and iron accumulation in kidneys of mice was detected by Prussian blue staining. Western blotting, immunohistochemistry, and immunofluorescence were used to investigate the presence of inflammation, oxidative stress, mitochondrial dysfunction, iron deposition, and lipid peroxidation in mouse kidneys.Results: Active ingredients in SSF had strong affinities with ferroptosis. SSF reduced SCr (p< 0.01) and BUN (p< 0.0001) levels, pathological damage (p< 0.0001), dead cells in the tubular epithelium (p< 0.0001) and iron deposition (p< 0.01) in mice with cisplatin induced AKI. And SSF downregulated macrophage infiltration (p< 0.01), the expressions of high mobility group box 1 (HMGB1, p< 0.05) and interleukin (IL)-17 (p< 0.05), upregulated superoxide dismutase (SOD) 1 and 2 (p< 0.01), and catalase (CAT, phttps://www.dovepress.com/shenshuaifu-granule-attenuates-acute-kidney-injury-by-inhibiting-ferro-peer-reviewed-fulltext-article-DDDTacute kidney injurycisplatinferroptosisshenshuaifu granulep53/slc7a11/gpx4 pathway |
| spellingShingle | Jin X He R Lin Y Liu J Wang Y Li Z Liao Y Yang S Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway Drug Design, Development and Therapy acute kidney injury cisplatin ferroptosis shenshuaifu granule p53/slc7a11/gpx4 pathway |
| title | Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway |
| title_full | Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway |
| title_fullStr | Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway |
| title_full_unstemmed | Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway |
| title_short | Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway |
| title_sort | shenshuaifu granule attenuates acute kidney injury by inhibiting ferroptosis mediated by p53 slc7a11 gpx4 pathway |
| topic | acute kidney injury cisplatin ferroptosis shenshuaifu granule p53/slc7a11/gpx4 pathway |
| url | https://www.dovepress.com/shenshuaifu-granule-attenuates-acute-kidney-injury-by-inhibiting-ferro-peer-reviewed-fulltext-article-DDDT |
| work_keys_str_mv | AT jinx shenshuaifugranuleattenuatesacutekidneyinjurybyinhibitingferroptosismediatedbyp53slc7a11gpx4pathway AT her shenshuaifugranuleattenuatesacutekidneyinjurybyinhibitingferroptosismediatedbyp53slc7a11gpx4pathway AT liny shenshuaifugranuleattenuatesacutekidneyinjurybyinhibitingferroptosismediatedbyp53slc7a11gpx4pathway AT liuj shenshuaifugranuleattenuatesacutekidneyinjurybyinhibitingferroptosismediatedbyp53slc7a11gpx4pathway AT wangy shenshuaifugranuleattenuatesacutekidneyinjurybyinhibitingferroptosismediatedbyp53slc7a11gpx4pathway AT liz shenshuaifugranuleattenuatesacutekidneyinjurybyinhibitingferroptosismediatedbyp53slc7a11gpx4pathway AT liaoy shenshuaifugranuleattenuatesacutekidneyinjurybyinhibitingferroptosismediatedbyp53slc7a11gpx4pathway AT yangs shenshuaifugranuleattenuatesacutekidneyinjurybyinhibitingferroptosismediatedbyp53slc7a11gpx4pathway |